Home » Topics » BioWorld Science

BioWorld Science
RSS

Sellas reports phase I data on galinpepimut-S with nivolumab in malignant pleural mesothelioma

June 25, 2021

Fulcrum reports phase IIb data on losmapimod in FSHD

June 25, 2021

CStone reports data on Gavreto in Chinese patients with advanced RET fusion-positive NSCLC

June 25, 2021

Study supports miR panel for diagnosing multiple sclerosis

June 25, 2021

Mercaptor advances programs in COVID-19 brain inflammation and epilepsy

June 25, 2021

Titan reports in vivo data on TP-2021 implant in model of chronic pruritus

June 25, 2021

Seal Rock begins phase I trial of SRT-015 for NASH

June 25, 2021

First-in-human study of BDB-018 explores use in advanced solid tumors

June 25, 2021

XBiotech initiates trial of XB-2001 with chemotherapy for pancreatic cancer

June 25, 2021

Karuna reports phase Ib data on KarXT in healthy elderly volunteers

June 25, 2021

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...